Author

Simon J. Hogg

Memorial Sloan Kettering Cancer CenterORCID 0000-0002-3170-839XUnclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Genomics· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:differential expression· 1 Research Focus:gene regulatory network inference· 1 Assay:proteomics· 1 Approach:statistical model· 1

Frequent Co-Authors

Alessandro GardiniiD· 1 shared Andrea NewboldiD· 1 shared Ben P. Martin· 1 shared Benjamin F. CravattiD· 1 shared Benjamin J. BlythiD· 1 shared Bruno N. MelilloiD· 1 shared Caroline G. WebsteriD· 1 shared Charles D. Warren· 1 shared

Activity by Year

2021-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperGenomics

Alessandro GardiniORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

ImmunologyCell chemical biologyPeer-reviewedNov 25, 2024

Covalent Targeting of Splicing in T Cells.

Kevin A. Scott, Hiroyuki Kojima, Nathalie Ropek…·Ekaterina V. Vinogradova

This study develops chemical probes to target splicing factors in T cells, showing state-dependent loss of ITK via SF3B1 and demonstrating covalent ligandability of splicing regulators.

16 citations

humanproteomics

𝕏 PostBluesky

GenomicsCellPeer-reviewedMay 17, 2021

A PP2A-Integrator complex fine-tunes transcription by opposing CDK9

Stephin J. Vervoort, Sarah A. Welsh, Jennifer R. Devlin…·Ricky W. Johnstone

The paper identifies a PP2A-Integrator complex that opposes CDK9 activity to regulate transcription and shows its therapeutic synergy in leukemia.

221 citationstop 1%

humanbulk RNA-seq

𝕏 PostBluesky